Jardiance Tablet 10 mg (Empagliflozin)

Adult dose

For Type 2 diabetes: The recommended dosage is 10 mg once daily for monotherapy and adjunctive therapy with insulin and other glucose-lowering medications. If the patient exhibits good tolerability and requires additional blood sugar control, the dosage may be increased to 25 mg once daily. For chronic heart failure: 10 mg once daily. For chronic kidney disease: 10 mg once daily, co-administered with other standard therapies for chronic kidney disease. This medication can be taken regardless of meals.

This medication should not be used in patients with allergies to the active ingredient or any components. It should also not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Furthermore, patients with lactose intolerance or specific genetic metabolic disorders should avoid this medication. Patients with diminished renal function should use this medication cautiously and kidney function should be regularly monitored before and during treatment. It is not recommended for patients with severe kidney impairment or those on dialysis. When taken with insulin or insulin secretagogues like sulfonylureas, there may be a risk of hypoglycemia, so dosage adjustments may be necessary. This medication can cause various side effects such as hypoglycemia, genital infections, urinary tract infections, volume depletion, and increased urination. Elderly patients or those at risk for volume depletion should be particularly cautious of side effects. Severe metabolic disturbances such as ketoacidosis can occur, so if symptoms like vomiting, abdominal pain, or difficulty breathing arise, immediate consultation with a healthcare provider is required. This medication may also pose a risk of liver damage, so symptoms of liver dysfunction should be reported. Additionally, there is a rare risk of severe infections such as necrotizing fasciitis, so if pain, swelling, or redness occurs around the genital area, immediate medical attention is necessary. Women who are pregnant or planning to become pregnant should avoid this medication, and if pregnancy is confirmed, it should be discontinued immediately. Nursing mothers should also discontinue breastfeeding while taking this medication. It is not used in children under the age of 18 as its safety and efficacy have not been established. When taking this medication, caution should be exercised to reduce the risk of hypoglycemia while driving or operating machinery. There have been no reports of specific toxicity with overdose, but if symptoms occur, immediate medical attention should be sought. This medication should be kept out of the reach of children and should not be transferred to other containers.

Serious side effects

Hives, severe swelling (edema), ketoacidosis, angioedema, necrotizing fasciitis, urinary tract sepsis, pyelonephritis, severe rash accompanied with high fever, blisters, skin peeling, oral/ocular mucosal pain, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough + fever, yellowing of the skin or eyes (jaundice), extreme malaise, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances.

Mild side effects

• Hypoglycemia
• constipation
• itching
• rash
• angi edema
• increased urination
• difficulty urinating
• interstitial nephritis
• thirst
• increased serum lipids

This medication should be stored in a tightly closed container to protect it from air and moisture, at a temperature between 1 and 30 degrees Celsius. Proper storage will maintain the efficacy and safety of the medication.

Appearance

Light yellow, round, biconvex film-coated tablet with rounded edges

Package unit

30 tablets/PTP [(10 tablets/PTP * 3)], 10 tablets/PTP [(10 tablets/PTP * 1)]